Mahmood Ahmad
Tahir Heart Institute
author@example.com

Protocol: CT.gov Country Ghost Watchlist

This protocol re-reads the country-linked wave-nine watchlist with excess ghost-protocol stock at the center rather than adjusted missing-results stock alone. Primary outputs compare excess ghost stock, raw ghost counts, black-box stock, and black-box rate across country-linked portfolios. The aim is to isolate deeper silence than overdue results alone. Because portfolios are country-linked rather than mutually exclusive, multinational studies can contribute to more than one national row.

Outside Notes

Type: protocol
Primary estimand: Excess ghost-protocol stock across country-linked study portfolios
App: CT.gov Country Ghost Watchlist dashboard
Code: https://github.com/mahmood726-cyber/ctgov-country-ghost-watchlist
Date: 2026-03-29
Validation: FULL REGISTRY RUN

References

1. ClinicalTrials.gov API v2. National Library of Medicine. Accessed March 29, 2026.
2. DeVito NJ, Bacon S, Goldacre B. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study. Lancet. 2020;395(10221):361-369.
3. Zarin DA, Tse T, Williams RJ, Carr S. Trial reporting in ClinicalTrials.gov. N Engl J Med. 2016;375(20):1998-2004.

AI Disclosure

This work represents a compiler-generated evidence micro-publication built from structured registry data and deterministic summary code. AI was used as a constrained coding and drafting assistant for interface generation, packaging, and prose refinement, not as an autonomous author. The analytical choices, interpretation, and final outputs were reviewed by the author, who takes responsibility for the content.